Full-Time

Market Access Lead

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

No salary listed

Toronto, ON, Canada

Hybrid

Hybrid work environment with expectation to be in-office 2-3 days per week, or approximately 8+ days per month, depending on business needs.

Category
💬Consulting (1)
Required Skills
Financial analysis
Data Analysis
Requirements
  • Minimum 5-7 years within pharmaceutical, biotechnology, HTA, or consulting industry. Previous Oncology experience mandatory.
  • Strong understanding of the current pharmaceutical industry, specifically the Oncology business and payer and market access environment.
  • Ability to lead without authority, to envision, enroll, and engage internal cross-functional partners, and to deliver strategic partnerships with patient organizations.
  • Strong negotiation capabilities, strong interpersonal, presentation, and communication skills, scientific and analytical skills.
  • Demonstrated business acumen, financial analysis, and strong project management capabilities. Attention to detail and develop business cases to support strategies and obtain local, regional and global pricing approval.
  • Ability to establish collaborative, trusting partnerships to drive common priorities with external customers. Establish active and compliant partnerships with patient organizations and communities.
  • Ability to collect, analyse, and interpret data to make informed decisions and drive business outcomes.
  • Dedication to leading by example through intentional skill development, experimentation and fostering a culture of digital curiosity within the organization.
  • Experience working effectively with colleagues in virtual or remote settings, utilizing digital collaboration tools, incl. MS Teams.
  • Proficiency in leveraging digital tools, platforms, Artificial Intelligence (AI) and other technologies (including Microsoft Office suite) to communicate with impact and perform tasks efficiently and effectively.
  • Understanding of cybersecurity threats and best practices to protect sensitive information and systems.
  • Prior experience in driving digital transformation initiatives, showcasing a strategic mindset towards technology innovation and integration with daily work practices.
Responsibilities
  • Leadership of Oncology market access, including clinical and economic evidence, gap identification, and cancer agency engagement for the oncology portfolio. Responsible for strategy, development, and presentation for the oncology portfolio for HTA submissions and other interactions with cancer agencies and payors.
  • Include market access planning as part of the oncology brand strategy process for new and existing products. Provide input into the broader marketing plan, including the development of critical success factors and execution of required tactical plans.
  • Develop strategic pricing strategies for new products and new launches (e.g., indications, line extensions) and solve complex strategic and business challenges related to payer reimbursement.
  • Develop in-depth analysis of business cases (P&L) with cross-functional partners (finance, marketing) for negotiation strategies pertaining to the Oncology portfolio. Secure all internal price approvals, and ensure compliance under SOPs.
  • Ensure PMPRB compliance, proactively identify potential risks, and lead risk mitigation strategies.
  • Be accountable for the operations of Product Listing Agreements (PLA) including analysis, invoice validations, troubleshooting, and data collection as needed for oncology products. Ensure compliance for mandatory data reporting as required by Provinces.
  • Responsible for the relationship with Oncology related patient organizations for inline and pipeline products. Work in close collaboration with Takeda Canada Patient Engagement Lead, Medical, Regulatory, and other cross-functional team members to ensure the delivery of a seamless strategy and plan for Takeda.
  • Work closely and align with the Takeda Canada Pricing Value and Access team on customer strategies and engagements.
  • Ensure a thorough understanding of Takeda’s Code of Ethical Practices, IMC Code of Ethics, and Takeda’s SOPs. Upholding a commitment to compliance and operating with integrity within all business objectives.
Desired Qualifications
  • Relevant experience in areas of health technology assessment, value proposition, pharmaceutical pricing, health economics, oncology payors, PMPRB/pricing strategies is preferred.
  • Advanced degree in business administration or science is preferred.
  • Bilingualism (English/French) is an asset.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines for patients. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized in all operations.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Value Analytics Labs could enhance market access strategies.
  • Integration with Salesforce's AI may improve patient and provider engagement.
  • Recognition as a top workplace could attract talent and support growth.

What critics are saying

  • Departure of key executive Richard Ascroft may lead to leadership gaps.
  • Alleged data breach could result in reputational damage and legal liabilities.
  • Ongoing antitrust case with Meijer could lead to financial penalties.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company focuses on patient-centric values and environmental sustainability.
  • Takeda has a robust pipeline with 11 NMEs and aims for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

The Derm Digest
Jun 26th, 2025
Richard Ascroft Named CEO North America of Sun Pharma

Richard joins Sun Pharma from Takeda Pharmaceuticals where he most recently served as Senior Vice President and Business Unit Head of U.S. Plasma-Derived Therapies and was a member of both the U.S. and global executive leadership teams.

Cancer Research Horizons
Jun 23rd, 2025
Adaptate Biotherapeutics raises $18 million in a series A2 funding

Adaptate Biotherapeutics announced that its existing investors, Abingworth and Takeda, have together made a further equity investment of $18 million.

Schott Pharma
Jun 20th, 2025
Closed loop recycling of pharmaceutical transport packaging aids decarbonization

To create a new, circular solution appropriate for pharmaceutical manufacturing, SCHOTT Pharma partnered with Corplex, a packaging manufacturer, and with Takeda and Pfizer respectively, both leading pharmaceutical companies.

SuperAdrianMe
Jun 5th, 2025
Takeda Ukraine & Bulgaria Earn #8 Global Ranking in Best Places to Work 2024

LONDON, UK - Media OutReach Newswire - 5 June 2025 - Takeda, a global value-based, R&D-driven biopharmaceutical company, has been proudly recognized as one of the Top 10 Best Places to Work in the World for 2024, achieving the No. 8 global ranking by both Ukraine and Bulgaria countries.

Pharmashots
Jun 2nd, 2025
Takeda at ASH 2024: Phuong Khanh Morrow from Takeda in a Riveting Conversation with PharmaShots

Takeda at ASH 2024: Phuong Khanh Morrow from Takeda in a riveting conversation with pharmashots.